One-Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real-World Study. [PDF]
Chinese patients with acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator (IV rt‐PA) within 4.5 h of symptom onset had similar rates of all‐cause mortality 1‐year post‐AIS compared with non‐reperfusion (11.1% vs. 12.2%, respectively).
Xue R+10 more
europepmc +2 more sources
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. [PDF]
Tsunehiro Yasuda+9 more
openalex +1 more source
Effect and mechanism of stem cells and exosomes therapy in ischemic stroke. The effect and mechanism include protection of neuron and glial cells, repairment of nerve vascular unit, reduction of inflammation response, restoration of white matter integrity, reconstruction of neural circuit, replacement of neurons and glial cells, and anti‐ferroptosis ...
Weihong Du+4 more
wiley +1 more source
The role of the host—Neutrophil biology
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple+4 more
wiley +1 more source
Abstract Objective Evaluate the use of tranexamic acid (TXA) and observation as a management option for pediatric patients presenting with posttonsillectomy hemorrhage (PTH). Study Design Retrospective analysis of a prospectively implemented quality improvement initiative with a historical control comparison group. Setting Tertiary children's hospital.
Laura A. Petrauskas+12 more
wiley +1 more source
Streptolysin O accelerates the conversion of plasminogen to plasmin
Group A Streptococcus (GAS) is a human-specific bacterial pathogen that can exploit the plasminogen-plasmin fibrinolysis system to dismantle blood clots and facilitate its spread and survival within the human host.
Di Tang+6 more
doaj +1 more source
Insights Into Effects of Natural Bioactive Components on Inflammatory Diseases in Respiratory Tract
ABSTRACT The increasing prevalence of inflammatory diseases in the respiratory tract worldwide has raised concerns, and due to its high prevalence and poor prognosis, it remains a clinical focus and research hotspot. These inflammatory diseases include airway inflammation, asthma, bacterial antigens‐induced tonsil epithelial inflammation, chronic ...
Jincan Luo+4 more
wiley +1 more source
The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation
Chronic inflammatory diseases, such as rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, Crohn’s disease, periodontitis, and carcinoma metastasis frequently result in bone destruction.
Yosuke Kanno
doaj +1 more source
The structure of synthesized cerium oxide nanoparticles (CeNPs) reveals antioxidative properties. CeNP reduces reactive oxygen species and shows good biocompatibility in muscle satellite cells. CeNP‐treated mice exhibit long‐acting anti‐sarcopenic effects through improved muscle mass and strength.
Wei‐Chih Lien+7 more
wiley +1 more source
Postoperative Changes in the Plasmatic Levels of Tissue-Type Plasminogen Activator and Its Fast-Acting Inhibitor - Relationship to Deep Vein Thrombosis and Influence of Prophylaxis [PDF]
José A. Páramo+2 more
openalex +1 more source